Document Page: First | Prev | Next | All | Image | This Release | Search

File: 120396_mar96_decls7_0016.txt
Page: 0016
Total Pages: 17

Subject: DAILY STAFF JOURNAL 12 NOV 90                                   

Unit: XVIII CORPS 

Parent Organization: ARCENT      

Box ID: BX000036

Folder Title: DUTY LOG G3  EOC INCOMING MSGS  12 NOV 90                                                       

Document Number:          2

Folder SEQ  #:         34





                                            UNCLASSIFIED




                    RAASZYUW RUDCHAA0120 3381605        RHILHAS.
                    ZNY
                    R 12120OZ NOV 90
                    FM COMUSARCENT MAIN//63-NBC//
                    TO AIG 11742
                    BT


                    SUBJ: ISSUE OF NERVE AGENT PYRIODSTIGMINE PRETREATMENT (NAPP) (U)
                    A.    UNCLASSIFIED MSG, COMUSNAVCENT, 192248Z AUG 90, SUBJ: SAB.
                    1.    @ 'ARCENT POLICY IS THAT THERE ARE 3 NAPPS PER SOLDIER.
                    STRONGLY RECOMMEND UNIT COMMANDERS ISSUE ONE NAPP TO INDIVIDUAL
                    SOLDIER AND POSITION 2 ADDITIONAL NAPPS PER SOLDIER AT COMPANY LEVEL.
                    REFRIGERATE UNIT STORED NAPP IF POSSIBLE, AT THE rINIMU,'), KEEP NAPP
                    FROM DIRECT SUNLIGHT. NAPP, NSN 6505-01-178-7903, IS IN THE AOR AND
                    CAN BE ORDERED THROUGH SUPPLY SYSTEM.
                    2.        NAPP ENHANCES THE EFFECTIVENESS OF MARK I NERVE AGENT
                    ANTIDOTE KITS. IF TAKEN WITHIN 8 HRS OF NERVE AGENT (NA) EXPOSURE,
                    IT REDUCES THE SEVERITY OF NERVE AGENT POISONING, SHORTENS THE
                    DURATION OF TREATMENT, AND INCREASES SURVIVAL OF NERVE AGENT
                    CASUALTIES. 21 NAPP TABLETS COME IN A BLISTER PACKAGE THAT CONTAINS
                    ENOUGH TABLETS FOR 7 DAYS (I TABLET EVERY 8 HOURS).
                    3.        NAPP TABLET SETS SHOULD BE REFRIGERATED IN TEMPERATURE




           PAGE 02 RUDCHAA0120
                    RANGES (IF 35-4b DEGREES FARENHEIT (2-8 DEGREES CENTIGRADE). IF NAPP
                    IS NOT REFRIGERATED, ITS SHELF LIFE IS 6 MONTHS.
                    4.    (U) THE FOLLOWING EXCERPT FROM REF A PROVIDES ADDITIONAL
                    INFORMATION ON NAPP:
                    A.    (U) FOR THE GREATEST EFFECT, ONE PYRIDOSTIGMINE TABLET SHOULD
                    BE TAKEN EVERY EIGHT HOURS ON A CONTINDUS BASIS BEFORE A NERVE AGENT
        ATTACK UNTIL ORDERS ARE ISSUED TO DISCONTINUE. COMMANDERS
                    SHOULD REEVALUATE THREAT LEVELS IF NO ATTACK HAS OCCURRED WITHIN 72
                    HOURS OF PYRIDOSTIGMINE PRETREATMENT.
                    B.    (U) WHEN ORDERED TO BEGIN TAKING NAPP, TAKE ONE 30-MG TABLET
                    BY MOUTH, WITH SUFFICIENT WATER, AND CONTINUE TO TAKE ONE
                    EVERY EIGHT HOURS AS DIRECTED BY THE COMMANDING OFFICER. IF A DOSE
                    IS MISSED, DO NOT MAKE IT UP. DO NOT TAKE TWO TABLETS AT ONCE
                    BECAUSE OF MISSED DOSE--START AGAIN WITH ONE TABLET EVERY EIGHT
                    HOURS. TAKING TWO TABLETS AT ONCE COULD RESULT IN ADVERSE SIDE
                    EFFECTS. (CAUTION: TAKING MORE THAN ONE TABLET AT A TIME DOES NOT
                    PROVIDE ADDITIONAL PROTECTION. IN FACT, IT MAY BE MORE HAZARDOUS IF
                    THERE IS SUBSEQUENT EXPOSURE TO NA). DO NOT TAKE NAPP WHILE MASKED
                    IN A CHEMICALLY CONTAMINATED AREA.
                    C.    (U) SIGNS/SYMPTOMS OF PYRIDOSTIBMINE OVERDOSE AND ALLERGIC
                                                   DECLASSIFIED
                                                   ON: 15 OCT 96
           @AGE 03 RUDCHAA012                      BY: SEC ARMY (DAMH) UNDER SEC 3.4 EO
                    REACTIONS. ALTHOUGH NO DETRIri2WEFFECTS ARE EXPECTED AT THE
                    RECOMMENDED DOSAGE, DEPENDING ON LENGTH OF TIME AND AMOUNT OF
                    MEDICATION TAKEN ALONG WITH INDIVIDUAL PSYSIOLOGICAL VARIATIONS,
                    CERTAIN INDIVIDUALS MAY EXPERIENCE THE FOLLOWING ADVERSE REACTIONS
                    FROM PYRIDOSTISMINE:    ABDOMINAL CRAMPS, NAUSEA, DIARRHEA, SKIN RASH,
                    WEAKNESS, MUSCLE CRAMPS, MUSCULAR TWITCHING AND/OR DIMNESS OF VISION
                    DUE TO PINPOINTED PUPILS. IF ANY OF THESE SIGNS/SYMPTOMS OCCUR, THE
                    SOLDIER SHOULD CHECK WITH MEDICAL PERSONNEI
ATMENT ADMINISTERED FOR PYRIDOSTIGMINE-

Document Page: First | Prev | Next | All | Image | This Release | Search


Document 17 f:/Week-10/BX000036/DUTY LOG G3 EOC INCOMING MSGS 12 NOV 90/daily staff journal 12 nov 90:11089615153056
Control Fields 17
File Room = mar96_declassified
File Cabinet = Week-10
Box ID = BX000036
Unit = XVIII CORPS
Parent Organization = ARCENT
Folder Title = DUTY LOG G3 EOC INCOMING MSGS 12 NOV 90
Folder Seq # = 34
Subject = DAILY STAFF JOURNAL 12 NOV 90
Document Seq # = 2
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 08-NOV-1996